Division of Biomedical Sciences, Clinical Science Research Laboratories, Warwick Medical School, University of Warwick, Coventry CV2 2DX, UK.
Reproductive Immunology and Implantation, Vrije Universiteit Brussel (VUB), Laarbeeklaan 103, Brussels, Belgium.
Mol Hum Reprod. 2017 Jul 1;23(7):478-487. doi: 10.1093/molehr/gax023.
Is implantation failure following ART associated with a perturbed decidual response in endometrial stromal cells (EnSCs)?
Dynamic changes in the secretome of decidualizing EnSCs underpin the transition of a hostile to a supportive endometrial microenvironment for embryo implantation; perturbation in this transitional pathway prior to ART is associated with implantation failure.
Implantation is the rate-limiting step in ART, although the contribution of an aberrant endometrial microenvironment in IVF failure remains ill defined.
STUDY DESIGN, SIZE, DURATION: In vitro characterization of the temporal changes in the decidual response of primary EnSCs isolated prior to a successful or failed ART cycle. An analysis of embryo responses to secreted cues from undifferentiated and decidualizing EnSCs was performed. The primary clinical outcome of the study was a positive urinary pregnancy test 14 days after embryo transfer.
PARTICIPANTS/MATERIALS, SETTING, METHODS: Primary EnSCs were isolated from endometrial biopsies obtained prior to IVF treatment and cryopreserved. EnSCs from 10 pregnant and 10 non-pregnant patients were then thawed, expanded in culture, subjected to clonogenic assays, and decidualized for either 2 or 8 days. Transcript levels of decidual marker gene [prolactin (PRL), insulin-like growth factor binding protein 1 (IGFBP1) and 11β-hydroxysteroid dehydrogenase (HSD11B1)] were analysed using real-time quantitative PCR and temporal secretome changes of 45 cytokines, chemokines and growth factors were measured by multiplex suspension bead immunoassay. The impact of the EnSC secretome on human blastocyst development was scored morphologically; and embryo secretions in response to EnSC cues analyzed by multiplex suspension bead immunoassay.
Clonogenicity and induction of decidual marker genes were comparable between EnSC cultures from pregnant and non-pregnant group groups (P > 0.05). Analysis of 23 secreted factors revealed that successful implantation was associated with co-ordinated secretome changes in decidualizing EnSCs, which were most pronounced on Day 2 of differentiation: 17 differentially secreted proteins on Day 2 of decidualization relative to undifferentiated (Day 0) EnSCs (P < 0.05); 11 differentially secreted proteins on Day 8 relative to Day 2 (P < 0.05); and eight differentially secreted proteins on Day 8 relative to Day 0 (P < 0.05). By contrast, failed implantation was associated with a disordered secretome response. Blastocyst development was compromised when cultured for 24 h in medium conditioned by undifferentiated EnSCs when compared to decidualizing EnSCs. Analysis of the embryo microdroplets revealed that human blastocysts mount a secretory cytokine response to soluble decidual factors produced during the early (Day 2) but not late phase (Day 8) of differentiation. The embryo responses to secreted factors from decidualizing EnSCs were comparable between the pregnant and non-pregnant group (P > 0.05).
Not applicable.
LIMITATIONS, REASONS FOR CAUTION: Although this study uses primary EnSCs and human embryos, caution is warranted when extrapolating the results to the in vivo situation because of the correlative nature of the study and limited sample size.
Our finding raises the prospect that endometrial analysis prior to ART could minimize the risk of treatment failure.
STUDY FUNDING AND COMPETING INTEREST(S): This work was supported by funds from the Biomedical Research Unit in Reproductive Health, a joint initiative of the University Hospitals Coventry & Warwickshire NHS Trust and Warwick Medical School, the University of Nottingham and Nurture Fertility, and the National Medical Research Council, Singapore (NMRC/BNIG14NOV023), the "Instituut voor Innovatie door Wetenschap en Technologie" (IWT, Flanders, Belgium), the "Fonds voor Wetenschappelijk Onderzoek" (FWO, Flanders, Belgium) and the "Wetenschappelijk Fonds Willy Gepts" (WFWG, UZ Brussel). The authors have declared that no conflict of interest exists.
ART 后种植失败是否与子宫内膜基质细胞(EnSCs)中蜕膜反应失调有关?
蜕膜化 EnSCs 分泌组的动态变化为胚胎着床提供了从敌对到支持子宫内膜微环境的转变;ART 前这种过渡途径的紊乱与着床失败有关。
尽管体外受精失败的子宫内膜微环境的贡献仍不清楚,但着床是辅助生殖技术的限速步骤。
研究设计、规模、持续时间:体外分析在成功或失败的辅助生殖周期前分离的原发性 EnSCs 的蜕膜反应的时间变化。分析胚胎对未分化和蜕膜化 EnSCs 分泌信号的反应。研究的主要临床结局是胚胎移植后 14 天尿妊娠试验阳性。
参与者/材料、设置、方法:从 IVF 治疗前和冷冻保存的子宫内膜活检中分离出原发性 EnSCs。然后解冻来自 10 名怀孕和 10 名未怀孕患者的 EnSCs,在培养物中进行克隆形成测定,并进行蜕膜化 2 或 8 天。使用实时定量 PCR 分析蜕膜标记基因[催乳素(PRL)、胰岛素样生长因子结合蛋白 1(IGFBP1)和 11β-羟类固醇脱氢酶(HSD11B1)]的转录水平,并通过多重悬浮珠免疫测定测量 45 种细胞因子、趋化因子和生长因子的时间分泌组变化。通过形态学评分评估 EnSC 分泌对人胚泡发育的影响;并通过多重悬浮珠免疫测定分析胚胎对 EnSC 信号的分泌反应。
来自怀孕和未怀孕组的 EnSC 培养物的克隆形成能力和诱导蜕膜标记基因的能力无差异(P>0.05)。对 23 种分泌因子的分析表明,成功的着床与蜕膜化 EnSCs 协调的分泌组变化有关,在分化的第 2 天最为明显:与未分化(第 0 天)EnSCs 相比,第 2 天有 17 种差异分泌蛋白(P<0.05);与第 2 天相比,第 8 天有 11 种差异分泌蛋白(P<0.05);与第 0 天相比,第 8 天有 8 种差异分泌蛋白(P<0.05)。相比之下,着床失败与紊乱的分泌反应有关。与诱导分化的 EnSCs 相比,在培养基中培养 24 小时时,胚泡发育受到损害。分析胚胎微滴发现,人胚泡对早期(第 2 天)但不是晚期(第 8 天)分化过程中产生的可溶性蜕膜因子产生分泌细胞因子反应。怀孕和未怀孕组胚胎对蜕膜化 EnSCs 分泌因子的反应无差异(P>0.05)。
不适用。
局限性、谨慎的原因:尽管本研究使用了原发性 EnSCs 和人类胚胎,但由于研究的相关性和样本量有限,在将结果推断到体内情况时需要谨慎。
我们的发现提出了一种可能性,即在辅助生殖技术前进行子宫内膜分析可以最大限度地降低治疗失败的风险。
这项工作得到了英国考文垂和沃里克郡大学医院与华威医学院、诺丁汉大学和 Nurture Fertility 之间的生殖健康生物医学研究单位、比利时“科学与技术创新研究所”(IWT)、比利时“佛兰德斯科学研究基金”(FWO)和“Willy Gepts 科学基金”(WFWG,布鲁塞尔大学)的资金支持。作者已声明不存在利益冲突。